(Q37759053)

22 August 2017

1 reference

title

When clinical trials make history: demonstrating efficacy of new antiepileptic drugs as monotherapy (English)

1 reference

22 August 2017

1

Emilio Perucca

1 reference

22 August 2017

publication date

1 October 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

51

1 reference

22 August 2017

issue

10

1 reference

22 August 2017

page(s)

1933-1935

1 reference

Conversion to monotherapy: clinical trials in patients with refractory partial seizures

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2010.02589.X

Historical control monotherapy design in the treatment of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2010.02589.X

An analysis of the placebo effect in Crohn's disease over time

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2010.02589.X

Placebo responses in randomized trials of antiepileptic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2010.02589.X

Designing clinical trials to assess antiepileptic drugs as monotherapy : difficulties and solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2010.02589.X

Monotherapy trials with the new antiepileptic drugs: study designs, practical relevance and ethical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2010.02589.X

Harnessing the clinical potential of antiepileptic drug therapy: dosage optimisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2010.02589.X

Meta-analysis of placebo rates in major depressive disorder trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2010.02589.X

10.1111/J.1528-1167.2010.02589.X

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference